CRSP crisprtx.com: Margin resik

crisprtx.com (CRSP) - logo korporat

The first gene therapy approvals establish a foundation for profitability, although cash flow remains limited by partnerships. The GURU.Markets interface displays this chart, where the commercial profit margin of CRISPR Therapeutics AG (CRSP) reaches -1812.10, reflecting the latest data. Business efficiency is supported by complex cryogenic logistics for biomaterials. Simultaneously, CRISPR Therapeutics AG (CRSP) is implementing green standards and clean energy across its laboratories.

crisprtx.com (CRSP) - Margin resik saka 04.07.2022 nganti 20.11.2026

CRISPR Therapeutics Corp - rincian analitis lan metrik utama (CRSP)

- rega saham lan prakiraan rega para ahli:
- data kapitalisasi saham perusahaan:
Analisis kabeh metrik perusahaan:CRISPR Therapeutics Inc - CRSP
Produk dadi CRISPR Therapeutics Inc

For the conservative investor, net margin dynamics serve as an efficiency filter, measuring the portion of net profit in every dollar of revenue after deducting all operating and tax expenses. In the case of CRISPR Therapeutics AG (CRSP), this indicator reflects the balance between the costs of ethical ESG optimization of biolabs and the ability of high-tech gene therapy to generate real free cash flow over the long term.

Pesaing utama

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Margin dodolan resik|Repligen Inc. - Margin bathi resik|Margin dodolan resik RNA|Margin dodolan perusahaan GeneDx|Margin resik Ultragenyx RARE|Margin dodolan perusahaan Beam Therapeutics (BEAM)|SRPT: Rentabilitas dodolan miturut bathi resik|Margin resik Twist Bioscience|TXG (10x Genomics) - Rentabilitas dodolan miturut bathi resik|Intellia Therapeutics, Inc. (NTLA) - Margin dodolan resik|Margin resik Stoke Therapeutics Inc|BLFS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik WVE (Wave Life Sciences Corp)|Margin dodolan perusahaan Maze Therapeutics Corp|Sionna Therapeutics Inc - Rentabilitas dodolan miturut bathi resik|PRME (primemedicine.com) - Margin bathi resik|TSHA - Margin resik|QURE (uniQure) - Rentabilitas dodolan resik|MeiraGTx Corp (MGTX) - Margin resik|Regenxbio - Tingkat bathi resik|Margin resik solidbio.com|Margin resik ocugen.com OCGN|Margin dodolan resik PACB|Benitec - Rentabilitas dodolan resik|Margin resik Design Therapeutics DSGN|Margin dodolan resik Rocket Pharmaceuticals RCKT|Margin bathi resik 4D Molecular Corp|LXEO: Margin resik|KRRO (Korro Bio, Inc) - Rentabilitas dodolan miturut bathi resik|Editas Medicine (EDIT) - Margin dodolan resik|Margin resik Silence Therapeutics Inc.|Rentabilitas dodolan resik PRQR (proqr.com)|Margin resik Codexis Bio (CDXS)|Margin dodolan resik sangamo.com (SGMO)|Margin resik nautilus.bio NAUT|Margin dodolan perusahaan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Margin dodolan resik|GBIO - Margin dodolan resik|BOLD: Margin dodolan resik|Rentabilitas dodolan resik XCUR|Margin resik Imunon|Phio Pharmaceuticals - Margin bathi resik|Margin resik Mustang Bio, Inc. (MBIO)|Margin dodolan perusahaan TransCode Therapeutics, Inc.|Margin resik Bionano Genomics BNGO|Tingkat bathi resik APDN|BLUE - Margin resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX